Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The primary objective of this study is to investigate whether two weeks of metformin treatment can activate the tumour microenvironment in patients with stage II and III oesophageal adenocarcinomas.
Epistemonikos ID: 1d9b0be0fa8762c546448f755d74eb6c1d88c022
First added on: Dec 01, 2024